Author:
Sathyan Sharad,Bhaskaran Madhu,Nair Vinay
Reference165 articles.
1. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998;9:2135–41.
2. Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001;12:1293–6.
3. Howard RJ, Patton PR, Reed AI, Hemming AW, Werf WJ Van der, Pfaff WW, Srinivas TR, Scornik JC. The changing causes of graft loss and death after kidney transplantation. Transplantation. 2002;73:1923–8.
4. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001;16:1545–9.
5. Knight SR, Russell NK, Barcena L, Morris PJ. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation. 2009;87:785–94.